ArticleAmerican journal of cancer research2024

Synergistic combination therapy with ONC201 or ONC206, and enzalutamide or darolutamide in preclinical studies of castration-resistant prostate cancer.

Laura Jinxuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.